Dr. Terri Phillips, Vice President and Global Head of Medical Affairs at Merz Americas, is building a first-rate medical affairs function to support the fastest growing aesthetics and neuroscience markets in the world. She discusses selecting the right neurotoxin for both aesthetic and therapeutic applications and blending technology with a personal touch to connect with physicians.
Terri L. Phillips, M.D., joined Merz in January 2018 as Vice President and Head of Global Medical Affairs. In this role, she oversees the medical affairs function for the company’s two businesses in medical aesthetics and neurosciences.
Dr. Phillips is widely recognized for her scientific, technical and business innovation expertise and has been in the pharmaceutical industry for more than 15 years. Prior to joining Merz, Dr. Phillips served as Vice President of Global Medical Affairs at Santen where she was responsible for organizational design and build up for the company’s first global medical affairs function. She also worked at Allergan for nine years, assuming increasingly expanded leadership roles. Dr. Phillips holds a bachelor’s degree from Bennett College and a doctor of medicine degree from Morehouse School of Medicine in Atlanta. She is dual board certified in neonatal/prenatal medicine and pediatrics.